GLOBEFLEX CAPITAL L P - EAGLE PHARMACEUTICALS INC ownership

EAGLE PHARMACEUTICALS INC's ticker is EGRX and the CUSIP is 269796108. A total of 180 filers reported holding EAGLE PHARMACEUTICALS INC in Q2 2019. The put-call ratio across all filers is 2.15 and the average weighting 0.1%.

Quarter-by-quarter ownership
GLOBEFLEX CAPITAL L P ownership history of EAGLE PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2022$3,252,000
+59.5%
73,205
+77.7%
0.79%
+92.0%
Q1 2022$2,039,000
-51.4%
41,205
-50.0%
0.41%
-4.0%
Q4 2021$4,196,000
+82.6%
82,410
+100.0%
0.43%
-14.3%
Q3 2021$2,298,000
+26.8%
41,205
-2.7%
0.50%
+54.0%
Q2 2021$1,813,000
+26.8%
42,357
+23.6%
0.33%
+24.9%
Q1 2021$1,430,000
-10.4%
34,2630.0%0.26%
-23.2%
Q4 2020$1,596,000
+12.0%
34,263
+2.1%
0.34%
-9.8%
Q3 2020$1,425,000
-6.3%
33,550
+5.8%
0.38%
-2.3%
Q2 2020$1,521,000
+76.2%
31,702
+69.1%
0.39%
+45.7%
Q1 2020$863,000
-23.4%
18,7510.0%0.26%
+25.6%
Q4 2019$1,127,000
+124.5%
18,751
+111.2%
0.21%
+91.8%
Q3 2019$502,000
+1.6%
8,8780.0%0.11%
+6.8%
Q2 2019$494,000
+10.3%
8,8780.0%0.10%
+8.4%
Q1 2019$448,000
+48.3%
8,878
+18.4%
0.10%
+31.9%
Q4 2018$302,000
-41.9%
7,5000.0%0.07%
-29.4%
Q3 2018$520,000
-38.6%
7,500
-33.0%
0.10%
-41.0%
Q2 2018$847,000
-48.0%
11,200
-63.8%
0.17%
-49.7%
Q1 2018$1,628,000
+16.2%
30,900
+17.9%
0.34%
-11.8%
Q4 2017$1,401,000
+39.0%
26,218
+106.4%
0.39%
+55.4%
Q4 2016$1,008,00012,700
+158650.0%
0.25%
Q2 2016$080.0%0.00%
Q1 2016$0
-100.0%
8
-99.8%
0.00%
-100.0%
Q4 2015$436,000
+20.1%
4,913
+0.2%
0.12%
+48.7%
Q3 2015$363,0004,904
+122500.0%
0.08%
Q2 2015$040.00%
Other shareholders
EAGLE PHARMACEUTICALS INC shareholders Q2 2019
NameSharesValueWeighting ↓
Park West Asset Management LLC 1,120,235$53,749,0002.66%
TANG CAPITAL MANAGEMENT LLC 255,616$12,264,0001.19%
Smith, Graham & Co., Investment Advisors, LP 158,671$7,613,0000.92%
ARMISTICE CAPITAL, LLC 282,000$13,530,0000.59%
Capital Impact Advisors, LLC 35,815$1,718,0000.57%
Matarin Capital Management, LLC 58,977$2,830,0000.56%
GLOBEFLEX CAPITAL L P 31,702$1,521,0000.39%
CHARTWELL INVESTMENT PARTNERS, LLC 200,246$9,608,0000.37%
Stanley-Laman Group, Ltd. 24,000$1,152,0000.28%
VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. 264$13,0000.20%
View complete list of EAGLE PHARMACEUTICALS INC shareholders